Your shopping cart is currently empty

HK2-IN-3 (compound 12) is a potent hexokinase 2 (HK2) inhibitor with an IC50 of 56.4 nM. It reduces glucose uptake and downregulates GLUT1/GLUT4 expression in oral squamous cell carcinoma (OSCC). HK2-IN-3 induces mitophagy (mitophagy) and apoptosis (apoptosis). In OSCC xenograft mouse models, HK2-IN-3 suppresses tumor growth and angiogenesis. It can be utilized in OSCC research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | HK2-IN-3 (compound 12) is a potent hexokinase 2 (HK2) inhibitor with an IC50 of 56.4 nM. It reduces glucose uptake and downregulates GLUT1/GLUT4 expression in oral squamous cell carcinoma (OSCC). HK2-IN-3 induces mitophagy (mitophagy) and apoptosis (apoptosis). In OSCC xenograft mouse models, HK2-IN-3 suppresses tumor growth and angiogenesis. It can be utilized in OSCC research. |
| Molecular Weight | 329.33 |
| Formula | C15H11N3O4S |
| Cas No. | 2679261-30-2 |
| Smiles | O=C(NN=CC1=CC=C(O)C(O)=C1O)C2=NC=3C=CC=CC3S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.